Loading…
SOPHiA GENETICS SA is projected to rise to $7.36 by 2027, a +30% move from its current price of $5.65. SOPH is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $5.50 | $5.65 | $5.81 | +0.06% |
| Jul 13 | $5.44 | $5.66 | $5.89 | +0.11% |
| Jul 14 | $5.39 | $5.66 | $5.94 | +0.17% |
| Jul 15 | $5.35 | $5.66 | $5.99 | +0.23% |
| Jul 16 | $5.32 | $5.67 | $6.03 | +0.28% |
| Jul 17 | $5.29 | $5.67 | $6.07 | +0.34% |
| Jul 18 | $5.27 | $5.67 | $6.11 | +0.40% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.27 | $5.67 | $6.11 | +0.40% |
| Week 2 | $5.13 | $5.69 | $6.33 | +0.79% |
| Week 3 | $5.03 | $5.72 | $6.50 | +1.19% |
| Week 4 | $4.95 | $5.74 | $6.66 | +1.59% |
| Week 5 | $4.88 | $5.76 | $6.80 | +1.99% |
| Week 6 | $4.82 | $5.79 | $6.94 | +2.40% |
| Week 7 | $4.77 | $5.81 | $7.07 | +2.80% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers the SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, applications, products, and services are used by hospitals, laboratories, and biopharmaceutical companies through its own sales force as well as distributors and industry collaborators in Switzerland, France, Italy, rest of Europe, North America, the United States, Latin America, and the Asia-pacific.
The company has a partnership with Synnovis to bring blood-based cancer testing to patients in the United Kingdom. The company was incorporated in 2011 and is based in Rolle, Switzerland.
SOPHiA GENETICS SA, listed with the symbol SOPH, has a current price of $5.69 and a market cap of $477.36M, ranking 3082 by market capitalization. The stock trades in a context of elevated volatility, with annualized volatility at 60%. The near-term outlook shows a neutral stance for 2026 with an average price of $5.69.
A major floor 27.4% below — a decisive break under it would weaken the trend.
The nearest floor, 15.4% below — buyers have tended to step in here.
The nearest ceiling, 5.8% above — a clean break opens room to run.
A major ceiling 18.1% above — clearing it would confirm fresh momentum.
Key SOPH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SOPH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.55 | Buy | $5.62 | Buy |
| MA 10 | $5.62 | Buy | $5.57 | Buy |
| MA 20 | $5.44 | Buy | $5.46 | Buy |
| MA 50 | $5.17 | Buy | $5.25 | Buy |
| MA 100 | $4.98 | Buy | $5.06 | Buy |
| MA 200 | $4.82 | Buy | $4.76 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 56.22 | Neutral |
| Stoch RSI (14) | 32.74 | Neutral |
| CCI (20) | 59.85 | Neutral |
| Williams %R (14) | -44.00 | Info |
| MACD (12,26,9) | 0.00 | Buy |
| ROC (12) | 8.03 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 56.00 | Neutral |
| TRIX (15) | 0.41 | Buy |
| Awesome (5,34) | 0.27 | Buy |
| Ultimate (7,14,28) | 48.99 | Neutral |
| Momentum (10) | -0.04 | Sell |
| Aroon Osc (25) | 68.00 | Buy |
| Hull MA (9) | 5.63 | Buy |
| ADX (14) | 13.10 | Neutral |
| ATR (14) | 0.16 | Info |
Technical sentiment is bullish. The RSI(14) is 60, suggesting room to move higher without being overbought. The 50-day simple moving average stands at $5.06, and the 200-day simple moving average is $4.71, indicating potential upside as the price navigates above these averages.
Key support is at $4.51 and resistance at $5.69, with a 30-day price range from $4.70 to $6.89.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.10 | $5.65 | $8.05 | 0% | Neutral | |
| $5.84 | $7.36 | $9.82 | +30% | Bullish | |
| $7.35 | $9.52 | $13.19 | +69% | Bullish | |
| $8.71 | $11.56 | $16.50 | +105% | Bullish | |
| $8.85 | $12.00 | $17.55 | +112% | Bullish | |
| $9.90 | $13.68 | $20.45 | +142% | Bullish | |
| $10.37 | $14.59 | $22.23 | +158% | Bullish | |
| $10.43 | $14.93 | $23.16 | +164% | Bullish | |
| $13.56 | $19.71 | $31.08 | +249% | Bullish | |
| $15.81 | $23.34 | $37.36 | +313% | Bullish | |
| $20.21 | $31.99 | $54.53 | +466% | Bullish | |
| $40.43 | $72.16 | $134.79 | +11.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.10 | $5.65 | $6.82 | +0.00% |
| August 2026 | $5.02 | $5.93 | $7.20 | +5.04% |
| September 2026 | $5.00 | $5.95 | $7.30 | +0.22% |
| October 2026 | $4.91 | $5.88 | $7.29 | -1.15% |
| November 2026 | $5.08 | $6.12 | $7.64 | +4.01% |
| December 2026 | $5.28 | $6.39 | $8.05 | +4.52% |
Click any year to see its month-by-month SOPH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SOPH price prediction for 2026 points to an average of $5.65 (low $4.10, high $8.05) — a potential gain of 0% on today's $5.65. A consolidation phase looks the most probable path here.
In 2027, SOPH is projected to trade between $5.84 and $9.82, averaging $7.36 — a potential gain of +30% from today's $5.65. That is up +30% on the projected 2026 average. Momentum favours further upside here.
SOPHiA GENETICS SA's 2028 outlook centres on $9.52, within a $7.35 to $13.19 range. That is up +29% on the projected 2027 average. That marks a +69% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, SOPH could reach as high as $16.50, with a base case around $11.56 and support toward $8.71 — roughly +105% from $5.65. Momentum favours further upside here.
Expect SOPH to range from $8.85 to $17.55 through 2030. The $12.00 average target implies a +112% move from current prices. That is up +4% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The SOPH price prediction for 2031 points to an average of $13.68 (low $9.90, high $20.45) — a potential gain of +142% on today's $5.65. Momentum favours further upside here.
In 2032, SOPH is projected to trade between $10.37 and $22.23, averaging $14.59 — a potential gain of +158% from today's $5.65. That is up +7% on the projected 2031 average. Buyers look set to stay in control over this stretch.
SOPHiA GENETICS SA's 2033 outlook centres on $14.93, within a $10.43 to $23.16 range. That is up +2% on the projected 2032 average. That marks a +164% change versus current levels. Momentum favours further upside here.
By 2034, SOPH could reach as high as $31.08, with a base case around $19.71 and support toward $13.56 — roughly +249% from $5.65. Buyers look set to stay in control over this stretch.
Expect SOPH to range from $15.81 to $37.36 through 2035. The $23.34 average target implies a +313% move from current prices. That is up +18% on the projected 2034 average. Momentum favours further upside here.
The SOPH price prediction for 2040 points to an average of $31.99 (low $20.21, high $54.53) — a potential gain of +466% on today's $5.65. Buyers look set to stay in control over this stretch.
In 2050, SOPH is projected to trade between $40.43 and $134.79, averaging $72.16 — a potential gain of +11.8x from today's $5.65. That is up +126% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in SOPH today (≈ 176.99115 SOPH) could be worth
$12,771.22
+$11,771.22 (+1177%) by 2050 · US Dollar
Based on the average projected SOPH price of $72.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SOPHwould be worth at today's price.
$1,000 invested in SOPH on Jul 10, 2025 (≈ 266.666667 SOPH) would be worth
$1,506.67
+$506.67 (+50.7%) today · 1.51× · US Dollar
Based on a SOPH entry price of $3.75 vs. today's $5.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.35 | $1,056.07 | +5.6% |
| 1 month ago | $5.22 | $1,082.38 | +8.2% |
| 3 months ago | $4.7 | $1,202.13 | +20.2% |
| 6 months ago | $5.15 | $1,097.09 | +9.7% |
| 1 year ago | $3.75 | $1,506.67 | +50.7% |
| All time (5.0y) ago | $16.76 | $337.11 | -66.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SOPH forecast.
Our base-case forecast reaches $11.00 around 2029.
Implied market cap at $11.00: $922.85M
The multi-year forecast shows a path of rising averages and strong upside potential. In 2027, the expected average price is $7.38 with a 29.7% ROI and bullish sentiment. The forecast continues higher through 2028 with an average of $9.63 and 69.3% ROI, and in 2029 an average of $11.50 with 102.1% ROI.
By 2030, the average is expected to be $11.90 with 109.2% ROI. The long arc extends to 2031 ($13.68, 140.4% ROI), 2032 ($14.17, 149.1%), and 2033 ($14.51, 155%). The 2034 forecast shows a notable jump to $19.77 (247.5% ROI), followed by 2035 at $22.75 (299.8% ROI).
Substantial gains are projected into 2040 with $31.48 average and 453.3% ROI, and into 2050 with $68.78 average and 1108.8% ROI. These are estimates and reflect upward momentum over the long term, with bullish sentiment accompanying the higher-average years, while acknowledging that outcomes can vary with market conditions and other factors.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $11.90 with a 109.2% ROI and bullish sentiment.
Near term shows a neutral stance in 2026 with an average price of $5.69, while the years 2027–2050 show bullish sentiment and rising averages, culminating in substantial long-term upside (e.g., 2040 average $31.48 with 453.3% ROI and 2050 average $68.78 with 1108.8% ROI).
Yes. The forecast projects an average of $19.77 in 2034 and $22.75 in 2035, indicating potential to reach and exceed $20 in the mid-2030s.
The 30-day range is $4.70 to $6.89.
Current price is $5.69 and market cap is $477.36M.
SOPHiA GENETICS SA Community Discussion
0Share your SOPHiA GENETICS SA price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.